Thursday May 16, 2019 0 comments
CASTLE ROCK -- In conjunction with its manufacturing partner, Ranfac Corp., Regenacell Therapy, Inc. announced the launch of the Lipo-Pro™ System, a new and innovative adipose harvesting and processing device.
The device allows for the sourcing of adipose aspirate and subsequent adipose graft preparation at point-of-care by retaining the cellular component of both the graft and infranatant while removing of the acellular components of oil and remaining infranatant.
Thomas D'Arcy, CEO of Regenacell Therapy, describes one of the primary advantages of the Lipo-Pro adipose harvesting and processing system as "allowing the clinician to acquire a small volume of adipose tissue and process it for a high-density adipose graft."
Another feature of the Lipo-Pro system that Bryan Mosley, president of Regenacell Therapy, touts is that it "provides a tool that allows physicians conducting autologous injection therapies to meet today's challenges in office-based procedure economics."
The Lipo-Pro System will be on display at the Regenacell Therapy booth during the TOBI annual meeting in Chicago, June 6-9.